January 28 th , 2019. On Saturday 3 rd February, the EC-funded project RECOPHARMA is holding an innovative workshop and science café at IPREM, Technopôle Helioparc near Pau, France. The workshop, “Monitoring of the occurrence and fate of CDs within the water cycle”, will provide a platform for expert speakers to share their latest research findings and will include presentations on traceability, chemical speciation, the chemical engineering approach and the environmental problems faced by the pharmaceutical industry during the production of cytostatic drugs. The workshop will conclude with a visit to the UPPA and IPREM research facilities. The focus of the follow-on Science Café, which takes place from 18:00 to 20:00, will be a discussion about RECOPHARMA activities, the occurrence and fate of Recalcitrant Cytostatic Drugs (CDs) in the water cycle, and
the project’s outputs and expected impact. This informal event aims at fostering interaction between all participants and experts as well as developing knowledge and awareness of responsible water and treatment of polluted water effluents. Project partner Leonardo Picinetti (Europe for Business) commented: “This opportunity for engagement will help stakeholders and the public to fully appreciate the interconnection of water with so many aspects of city life, and the importance of RECOPHARMA’s work.” This will be the first in a series of four Science Cafes organised by the RECOPHARMA Project in France, Italy, Cuba and Spain.
About the RECOPHARMA Project
The RECOPHARMA Project emerged from a need to develop an effective treatment to recover Recalcitrant Cytostatic Drugs (CDs) through the sequential integration of the potential offered by technologies such as Molecularly Imprinted Polymers (MIPs), Reagentless Thermosorption (RTS), Nanocomposites Functional Materials (NFMs) and Advanced Oxidation Processes (AOP). The RECOPHARMA Project, formed by 8 partners (see partners section), is a Research and Innovation Staff Exchange action, fostering intersectorial mobility between Europe and Cuba. Initiated on 01/01/2018, during the 48 months of the project, 107 exchanges will be carried out (199 P M). This project is co-financed by the Marie Skłodowska-Curie (MSCA) Research and Innovation Staff Exchange (RISE) of the European Research Framework Horizon2020 (with a budget of 895.000€).Co-funded by the Horizon 2020 Framework Programme of the European Union – Marie Skłodowska-Curie actions
For information about the RECOPHARMA H2020 project:
http://recopharma.eu
twitter: @recopharma_info
For information, contact:
Coordinator: Prof. Manuel Valiente
Universitat Autònoma de Barcelona,
Science Faculty. Building – Chemistry Department
08193, Bellaterra
Barcelona (Spain)
Tel: (+34) 93 581 49 38
E: info@recopharma.eu